K. Hoffmann

Cerebrospinal Fluid Neuropeptides and Monoaminergic Transmitters in Patients With Trigeminal Neuralgia

G. Hamann, K. Schimrigk, M. Grauer, 1997, Headache.

Leg oedema protection from a buckwheat herb tea in patients with chronic venous insufficiency: a single-centre, randomised, double-blind, placebo-controlled clinical trial

F. Jung, H. Kiesewetter, A. Müller, 1996, European Journal of Clinical Pharmacology.

Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer’s disease

T. Schneider-Axmann, P. Falkai, T. Bayer, 2006, Journal of Neural Transmission.

Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure

P. Vallance, M. Rambausek, E. Ritz, 1996 .

Decreased plasma cholesterol levels during aging in transgenic mouse models of Alzheimer's disease

P. Falkai, T. Bayer, O. Wirths, 2006, Experimental Gerontology.

Pattern of elevation of urine catecholamines in intracerebral haemorrhage

G. Hamann, K. Schimrigk, K. Wein, 2005, Acta Neurochirurgica.

Altered activity of the sympathetic nervous system and changes in the balance of hypophyseal, pituitary and adrenal hormones in patients with cluster headache

G. Hamann, K. Schimrigk, M. Grauer, 1996, Neuroreport.

Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure.

P. Vallance, M. Rambausek, E. Ritz, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Nephrology Dialysis Transplantation Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure

P. Vallance, M. Rambausek, E. Ritz, 2005 .

[Monoaminergic transmitters in the cerebrospinal fluid of patients with acute, chronic, and intermittent pain. Interface between pain and depression?].

S. Meyer, M. Strittmatter, C. Fischer, 2005, Der Nervenarzt.